CDC en Español

Search:

ISSN: 1080-6059

  • Email this page

Volume 15, Number 5–May 2009

Letter

Distinct Ecologically Relevant Strains of Anaplasma phagocytophilum

Janet E. Foley, Comments to Author Nathan C. Nieto, Robert Massung, Anthony Barbet, John Madigan, and Richard N. Brown
Author affiliations: University of California, Davis, California, USA (J.E. Foley, N.C. Nieto, J. Madigan); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (R. Massung); University of Florida, Gainesville, Florida, USA (A. Barbet); and Humboldt State University, Arcata, California, USA (R.N. Brown)

Suggested citation for this article

To the Editor: Anaplasma phagocytophilum was defined to include Ehrlichia phagocytophila, E. equi, and the agent of human granulocytic ehrlichiosis. Nevertheless, we and others have found phenotypic and genetic differences from diverse regions and hosts and conclude preliminarily that ecologically separate strains might exist that should be distinguished. Two precedents include ruminant strains of A. phagocytophilum in Europe and the Ap-Variant 1 from ruminants and ticks of North America and Europe.

In Europe, A. phagocytophilum infects livestock, rodents, and humans, with some species such as European cattle showing severe disease and high antibody prevalence. In contrast, cattle infection is rare in the United States, despite being common in other species. Experimental infection of cattle with California equine–origin strain MRK failed to induce disease or marked rickettsemia (1). Thus, even though European strains have ruminant tropism, an equine strain does not.

Ap-Variant 1 is found in ticks and deer in North America. This strain is distinctive in the 16S rRNA, major surface protein 4 (msp4), msp2, and ankA genes (2). Deer, goats, and tick-derived cell lines can be infected with Ap-Variant 1, but rodents cannot (3). Our recent data examining A. phagocytophilum in western North America show at least 2 phenotypes: strains originating from sciurids (chipmunks and tree squirrels) and strains from woodrats (the previously postulated reservoir). In a survey of 2,121 small mammals in areas of California with enzootic Ap-Variant 1, seroprevalence was highest in tree squirrels (71%), woodrats (50%), and chipmunks (up to 28%), and PCR prevalence was highest in tree squirrels (16%) and chipmunks (34%) (4). We showed that chipmunks were competent reservoirs for A. phagocytophilum through exposure in the field, successful inoculation with strain MRK, and transmission through Ixodes pacificus to mice. However, discrepancy in the phenotype of strains originating from woodrats and chipmunks is substantial when these strains are inoculated into horses. One chipmunk strain can infect both rodents and horses (important laboratory animal models for human infection), whereas woodrat strains show restricted rodent-only tropism.

A naturally infected redwood chipmunk was trapped in Mendocino County, California, exsanguinated, and documented to be positive for A. phagocytophilum by using real-time PCR, with a cycle threshold (Ct) of 31.31. An adult horse was negative for infection and exposure by PCR and immunofluorescence assay, premedicated with flunixin meglumine and diphenhydramine, and inoculated with 1.5 mL of infected chipmunk whole blood in EDTA. The mare was monitored daily for 16 days, including blood smear, serologic testing, and PCR, and assessment of behavior and attitude, rectal temperature, and legs for edema, swelling, or pain. She became ill 12 days postinoculation, with a body temperature of 40.0°C, lethargy, depression, and inappetance. Blood smears showed A. phagocytophilum morulae in neutrophils, and she was PCR positive on day 13 (Ct 37). Thus, infection from this chipmunk strain was indistinguishable from that induced when human-origin A. phagocytophilum was inoculated into this horse. The mare recovered after treatment.

In contrast, woodrat strains show rodent-host tropism but are not infectious to horses. We attempted to infect 3 horses with A. phagocytophilum from naturally infected, PCR-positive woodrats from Hoopa Valley, Humboldt County (1 pool of 4, 1 single) and Henry Cowell State Park, Santa Cruz County (N = 1); both sites are enzootic for A. phagocytophilum. Woodrats were bled into tubes containing EDTA, and blood was kept cool and screened that day by real-time PCR and serologic testing. The PCR-positive samples were divided into rodent and horse inocula. The horses were negative for infection and exposure using PCR and immunofluorescence assay, premedicated as described above, and then inoculated with 6 mL of A. phagocytophilum–infected woodrat blood. These horses never became infected on the basis of clinical signs, serology, blood smears, and PCR. Each horse was reinoculated 1–2 months later with 1.5 mL of an equine-tropic strain (MRK or chipmunk) to verify susceptibility to infection. All 3 became ill within 12–13 days postinoculation, with substantial increase in body temperature (>39.4°C), lethargy, depression, and inappetance. Blood smears showed A. phagocytophilum morulae in neutrophils, and the animals were PCR positive and seroconverted. We considered the woodrat inocula unlikely to be noninfectious because aliquots of the same samples produced rickettsemia according to PCR in C3H/HeJ mice and uninfected woodrats. All 3 horses recovered after treatment.

Appendix Figure
Appendix Figure.

Appendix Figure.

Although some woodrat A. phagocytophilum strains are genetically similar to human and equine strains, others differ from sciurid, human, horse, and dog strains, with conserved blocks within the msp2 gene (5). A phylogenetic tree based on the omp1n gene clusters a sciurid strain with local horses, distinct from northern California woodrats (Appendix Figure). Some woodrat strains have rodent-only tropism; Ap-Variant 1 does not infect rodents. Strains from sciurids and white-footed mice infect multiple laboratory animals and perhaps humans as well. Thus, epidemiologic studies evaluating human risk need to incorporate these distinctions and further ecologic and molecular genetic studies are necessary. With increasing reports of dissimilar genotypes of A. phagocytophilum from multiple regions of the world, defining distinct phenotypes and using nomenclature that appropriately clarifies the distinctions are important.

Acknowledgments

We thank Patrick Foley for helpful discussion and Nathaniel Lim for laboratory support.

Funding was provided by the National Institute for Allergy and Infectious Disease number RO1 GM081714.

References

  1. Hoar BR, Nieto NC, Rhodes DM, Foley JE. Evaluation of sequential coinfection with Anaplasma phagocytophilum and Anaplasma marginale in cattle. Am J Vet Res. 2008;69:1171–8. PubMed DOI
  2. de la Fuente J, Massung RF, Wong SJ, Chu FK, Lutz H, Meli M, et al. Sequence analysis of the msp4 gene of Anaplasma phagocytophilum strains. J Clin Microbiol. 2005;43:1309–17. PubMed DOI
  3. Massung RF, Levin ML, Munderloh UG, Silverman DJ, Lynch MJ, Gaywee JK, et al. Isolation and propagation of the Ap-Variant 1 strain of Anaplasma phagocytophilum in a tick cell line. J Clin Microbiol. 2007;45:2138–43. PubMed DOI
  4. Foley JE, Nieto NC, Adjemian J, Dabritz H, Brown RN. Anaplasma phagocytophilum infection in small mammal hosts of Ixodes ticks, western United States. Emerg Infect Dis. 2008;14:1147–50.
  5. Barbet AF, Lundgren A, Alleman R, Stuen S, Bjöersdorff A, Brown R, et al. Structure of the expression site reveals extensive global diversity in MSP2/P44 variants of Anaplasma phagocytophilum. Infect Immun. 2006;74:6429–37. PubMed DOI

Suggested Citation for this Article

Foley JE, Nieto NC, Massung R, Barbet A, Madigan J, Brown RN. Distinct ecologically relevant strains of Anaplasma phagocytophilum [letter]. Emerg Infect Dis [serial on the Internet]. 2009 May [date cited]. Available from http://www.cdc.gov/EID/content/15/5/842.htm

DOI: 10.3201/eid1505.081502

Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Janet E. Foley, Department of Medicine and Epidemiology, University of California, 1320 Tupper Hall, Davis, CA 95616, USA; email: jefoley@ucdavis.edu

Return email address:

Please note: To prevent email errors, please use no web addresses, email addresses, HTML code, or the characters <, >, and @ in the body of your message.

Comments to the EID Editors

Please contact the EID Editors at eideditor@cdc.gov

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.

This page posted April 21, 2009

Safer Healthier People

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435